Ilyang Pharm - Asset Resilience Ratio

Latest as of June 2025: 2.46%

Ilyang Pharm (007570) has an Asset Resilience Ratio of 2.46% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 007570 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩10.93 Billion

≈ $7.41 Million USD Cash + Short-term Investments

Total Assets

₩444.81 Billion

≈ $301.44 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Ilyang Pharm's Asset Resilience Ratio has changed over time. See Ilyang Pharm net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Ilyang Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Ilyang Pharm (007570) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.93 Billion	2.46%
Total Liquid Assets	₩10.93 Billion	2.46%

Asset Resilience Insights

Limited Liquidity: Ilyang Pharm maintains only 2.46% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Ilyang Pharm Industry Peers by Asset Resilience Ratio

Compare Ilyang Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Ilyang Pharm (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Ilyang Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.97%	₩8.49 Billion ≈ $5.76 Million	₩431.21 Billion ≈ $292.23 Million	+0.07pp
2023-12-31	1.90%	₩6.78 Billion ≈ $4.59 Million	₩356.66 Billion ≈ $241.70 Million	+0.81pp
2022-12-31	1.09%	₩5.42 Billion ≈ $3.67 Million	₩498.19 Billion ≈ $337.61 Million	-5.86pp
2021-12-31	6.95%	₩34.34 Billion ≈ $23.27 Million	₩494.27 Billion ≈ $334.96 Million	+6.89pp
2020-12-31	0.06%	₩270.87 Million ≈ $183.56K	₩439.12 Billion ≈ $297.58 Million	+0.05pp
2019-12-31	0.01%	₩43.52 Million ≈ $29.49K	₩437.46 Billion ≈ $296.46 Million	-1.25pp
2018-12-31	1.26%	₩5.46 Billion ≈ $3.70 Million	₩432.25 Billion ≈ $292.93 Million	+0.51pp
2017-12-31	0.76%	₩3.31 Billion ≈ $2.24 Million	₩436.37 Billion ≈ $295.72 Million	+0.75pp
2016-12-31	0.01%	₩43.85 Million ≈ $29.72K	₩431.26 Billion ≈ $292.26 Million	-0.07pp
2015-12-31	0.08%	₩354.85 Million ≈ $240.48K	₩431.63 Billion ≈ $292.51 Million	-0.06pp
2014-12-31	0.14%	₩594.84 Million ≈ $403.12K	₩430.83 Billion ≈ $291.97 Million	0.00pp
2013-12-31	0.14%	₩558.29 Million ≈ $378.34K	₩398.38 Billion ≈ $269.98 Million	-0.40pp
2009-12-31	0.54%	₩1.56 Billion ≈ $1.06 Million	₩289.86 Billion ≈ $196.44 Million	-7.55pp
2004-12-31	8.09%	₩15.41 Billion ≈ $10.44 Million	₩190.53 Billion ≈ $129.12 Million	+3.53pp
2003-12-31	4.56%	₩7.67 Billion ≈ $5.20 Million	₩168.29 Billion ≈ $114.05 Million	+1.37pp
2002-12-31	3.19%	₩5.56 Billion ≈ $3.76 Million	₩174.24 Billion ≈ $118.08 Million	--

pp = percentage points

About Ilyang Pharm

KO:007570 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$158.52 Million

₩233.92 Billion KRW

Market Cap Rank

#17539 Global

#738 in Korea

Share Price

₩13050.00

Change (1 day)

+0.00%

52-Week Range

₩12300.00 - ₩15130.00

All Time High

₩95982.23